Can the FRAX (Fracture Risk Assessment Tool) score replace DEXA (Dual-Energy X-ray Absorptiometry) scans for diagnosing osteoporosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can FRAX Replace DEXA?

No, FRAX cannot replace DEXA for diagnosing osteoporosis—DEXA remains the gold standard and is required for definitive diagnosis, while FRAX serves as a complementary risk stratification tool to guide treatment decisions in patients with low bone mass. 1

Why DEXA Cannot Be Replaced

Diagnostic Authority

  • DEXA is the only validated method for diagnosing osteoporosis using WHO criteria (T-score ≤ -2.5 at lumbar spine, femoral neck, total hip, or one-third radius). 1
  • FRAX does not measure bone mineral density and therefore cannot be used to make a diagnosis of osteoporosis—it only estimates fracture probability. 1
  • The WHO operational definition of osteoporosis requires either a T-score ≤ -2.5 on DEXA or a prior low-trauma major osteoporotic fracture. 1

Treatment Monitoring

  • DEXA is essential for monitoring treatment effectiveness, with follow-up scans recommended after 2 years of therapy. 2
  • FRAX scores change slowly over time and are not responsive enough to serve as a treatment target—change in FRAX score does not independently predict incident fractures. 3
  • Only DEXA provides the precision needed to detect clinically significant changes in bone density (least significant change of 2.8-5.6% depending on precision error). 1

The Complementary Role of FRAX

When FRAX Adds Value

  • FRAX is used in patients with osteopenia (T-score -1.0 to -2.4) to determine who needs pharmacologic treatment based on 10-year fracture probability. 1, 2
  • Treatment is recommended when FRAX shows ≥3% 10-year hip fracture risk or ≥20% 10-year major osteoporotic fracture risk. 1, 2
  • FRAX combined with DEXA BMD is more accurate than either alone for predicting fracture risk. 1

FRAX as a Screening Tool

  • In specific populations, FRAX can help identify who needs DEXA scanning rather than replacing it entirely. 4, 5
  • FRAX has high negative predictive value (94-100%) for ruling out patients who don't need DEXA, but low positive predictive value (0-16%) for identifying those who do. 4, 5
  • This means a normal FRAX score can help avoid unnecessary DEXA scans, but an abnormal FRAX score still requires DEXA confirmation. 4, 5

Clinical Algorithm

For postmenopausal women ≥65 years:

  • Perform DEXA as first-line screening—FRAX is not needed for initial diagnosis. 1

For postmenopausal women <65 years with risk factors:

  • Calculate FRAX score first to determine if DEXA is warranted. 1
  • If FRAX suggests low risk, DEXA may be deferred. 4, 5
  • If FRAX suggests intermediate or high risk, proceed with DEXA for definitive diagnosis. 1

For patients with osteopenia on DEXA:

  • Calculate FRAX using the femoral neck BMD to guide treatment decisions. 1, 2
  • Treat if fracture probability exceeds thresholds (≥3% hip or ≥20% major osteoporotic fracture). 1, 2

Important Limitations

FRAX Shortcomings

  • FRAX uses binary inputs (yes/no) for glucocorticoids and alcohol rather than quantified doses. 1
  • Does not incorporate lumbar spine BMD, trabecular bone score, fall history, or frailty. 1
  • Race-specific FRAX calculators may perpetuate disparities by always predicting lower risk in non-White populations with identical clinical profiles. 1
  • Based on cohort data that is 30-40 years old with mortality estimates not updated since 2004. 1

DEXA Limitations in Specific Populations

  • DEXA may overestimate BMD in patients with chronic kidney disease due to abdominal aortic calcifications—consider quantitative CT in these cases. 1
  • In patients with extensive spinal degenerative disease, severe obesity (BMI >35), or extreme body heights, quantitative CT may be superior to DEXA. 1

The bottom line: DEXA and FRAX serve different but complementary purposes—DEXA diagnoses osteoporosis and monitors treatment, while FRAX stratifies fracture risk to guide treatment decisions in the osteopenic range. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Low Bone Mass with Significant Fracture Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Can change in FRAX score be used to "treat to target"? A population‐based cohort study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2014

Research

FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2018

Related Questions

What is the clinical significance of a high Frax (Fracture Risk Assessment) score and how is it managed?
What FRAX (Fracture Risk Assessment) score indicates the need for osteoporosis treatment?
Does a 76-year-old female with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM) require treatment for low bone mass given her increased risk of fracture as indicated by a DEXA scan and FRAX calculation?
What is the role of the FRAX (Fracture Risk Assessment) tool in assessing osteoporosis risk and guiding treatment decisions?
At what Frax (Fracture Risk Assessment) score should osteoporosis be treated with medication?
How to manage a patient with hypokalemia (low potassium levels) and sinus arrhythmia (irregular heart rhythm)?
Is septoplasty (CPT 30520) medically necessary for a 47-year-old female with a deviated nasal septum, experiencing chronic sinus pressure and sinus pain, despite trying treatments such as antibiotics, nasal steroids, and nasal irrigations?
What is the treatment for cerebrovascular issues?
What is the differential diagnosis for an 18mm thick, heterogeneous, and hypervascular lesion in a patient with postmenopausal bleeding (PMB)?
Can digoxin be started in a patient with Chronic Kidney Disease (CKD) and a Glomerular Filtration Rate (GFR) of 17, who is not on dialysis, and has hypotension, Paroxysmal Atrial Fibrillation (PAFIB), and Heart Failure with reduced Ejection Fraction (HFrEF) of 25%?
What are the likely underlying diagnoses for a 44-year-old male with recent epididymitis, low average urine flow (oliguria), prolonged voiding time, and complete emptying, considering his age and medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.